Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM135A antisense RNA 1 (FAM135A-AS1) is a long non-coding RNA (lncRNA) transcribed antisense to the FAM135A gene. Antisense lncRNAs such as FAM135A-AS1 function primarily through regulatory mechanisms, including modulation of the expression of their sense (protein-coding) counterparts, alteration of chromatin structure, and interference with transcription. These molecules may regulate gene expression at both the transcriptional and post-transcriptional levels, often through cis-acting effects near their sites of synthesis. As of now, FAM135A-AS1 is not characterized as a classical therapeutic target (such as a receptor, enzyme, transporter, etc.), and there is limited evidence directly connecting it to specific disease mechanisms or therapeutic interventions. Most available information focuses on the general regulatory roles of antisense lncRNAs in gene expression and possible broad involvement in cancer and cell differentiation[1][3][5][6][7].
Regulation of target mRNA stability or transcription through antisense pairing; Chromatin modification and transcriptional interference
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FAM135A antisense RNA 1 (FAM135A-AS1).